0520

Gareth Jenkins, CSO at Arcinova, UK, outlines the steps pharma is taking to move towards a data-driven future in this month’s cover feature. In Profession, Robert Dudley, Chairman, CEO, and President of Clarus Therapeutics, discusses the lessons he has learned in a career dedicated to men’s health. And experts from across the industry take time to share their thoughts on how the COVID-19 pandemic is shaping their professional lives in our new Pandemic Diaries series.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Business & Regulation Trends & Forecasts

The Counterfeit COVID-19 Crisis

05/25/2020 | Stephanie Vine

How fakers are taking advantage of the pandemic.

Discovery & Development Drug Discovery

Stronger Together

05/18/2020 | Maryam Mahdi

A repurposed drug could help improve immunotherapy response rates.

Business & Regulation Business Practice

COVID-19 in Brief

05/05/2020 | Maryam Mahdi

What’s new in business?

Manufacture Bioprocessing - Upstream & Downstream

Editing for Purity

05/28/2020 | Stephanie Vine

Secretome engineering eliminates unwanted proteins in CHO-based bioprocessing.

Discovery & Development Drug Discovery

Better Use Case

05/23/2020 | Maryam Mahdi

Researchers are investigating the therapeutic value of immunotherapies for treating infectious diseases.

Discovery & Development Drug Discovery

Alleviating the Pressure

05/22/2020 | Maryam Mahdi

A gene therapy could help prevent the symptoms of glaucoma.

Manufacture Drug Discovery

Let There Be Light

05/29/2020

Using green light, a titanium catalyst could be a non-hazardous alternative to commonly used metal-based catalysts.

Manufacture Technology and Equipment

Winning Innovation

05/13/2020 | Stephanie Vine

Announcing the grand winner of The Medicine Maker 2019 Innovation Awards.

Discovery & Development Drug Discovery

Back to Immunity

05/13/2020 | Stephanie Vine

Can we reverse the effect of the ageing process on the immune system?

Discovery & Development Drug Discovery

Tracking the Pandemic

05/12/2020 | Maryam Mahdi

A clinical trial tracker aims to encourage international collaboration on COVID-19 drug development.

Manufacture Vaccines

The Pandemic Diaries

05/19/2020 | Mike Grippo, Andy Lane, Adrian Wildfire

We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

Manufacture Advanced Medicine

Viral Vectors in Vogue

05/05/2020 | Arvind Srivastava

We must collaborate to address stability challenges in viral vector manufacturing.

Manufacture Contract Manufacturing Services

Revving Up for the Revolution: Industry 4.0

05/27/2020 | Gareth Jenkins

We’re moving towards a data-driven future of enhanced manufacturing. And we must lay the foundations today.

Manufacture Process Control

Room for Optimization

06/01/2020

We speak with Richard Bourne about his work on pharmaceutical processes.

Manufacture Formulation

Navigating Technology Transfer for LNP Formulations

05/11/2020 | Larry Beiter

Technology transfer can be a challenge with any drug product. Even greater vigilance is needed with more complex formulations, like LNP-based drugs.

Discovery & Development Drug Delivery

Breathing New Life into Existing Drugs

05/20/2020 | Geraldine Venthoye

Inhaled administration has the potential to bring benefits to patients – and commercial success to businesses – across a number of therapeutic spaces.